Navigenics promises a peek at your genome — next year
Navigenics, which plans to offer individuals a personalized genetic analysis so they can better manage their health, “launched” its service — sort of — and announced that it has raised more than $25 million.
As we point out at VentureBeat Life Sciences, however, the company’s launch is really just a promise to begin its service early next year, at a price of $2,500 per person. Navigenics also lined up Mohr Davidow Ventures — an early backer of potential competitor 23andMe — as a new investor, and we’re also told that Google, which has both personal and financial ties to 23andMe, has quietly invested in Navigenics as well.
Next Story: Vaperma, for removing water from ethanol, raises CDN $21.5M
Previous Story: Whatsopen.com: Google's mobile local search effort?
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
